24 results
8-K
EX-2.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
, workers’ compensation, unemployment compensation and insurance, health insurance continuation, whistle-blowing, privacy rights, harassment (including … , immigration, safety and health, workers’ compensation, privacy and confidentiality, data security, the collection and payment of withholding social security
424B4
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
23 Nov 20
Prospectus supplement with pricing info
4:36pm
in the future.
We are subject to stringent privacy laws, information security laws, regulations, policies and contractual obligations related to data … privacy and security and changes in such laws, regulations, policies and contractual obligations could adversely affect our business, financial condition
DRS
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
8 Sep 20
Draft registration statement
12:00am
insurance coverage in the future.
We are subject to stringent privacy laws, information security laws, regulations, policies and contractual … obligations related to data privacy and security and changes in such laws, regulations, policies and contractual obligations could adversely affect our business
DRS/A
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
14 Oct 20
Draft registration statement (amended)
12:00am
are subject to stringent privacy laws, information security laws, regulations, policies and contractual obligations related to data privacy and security … of operations, cash flows and prospects.
We are subject to data privacy and protection laws and regulations that apply to the collection, transmission, storage
DRS/A
wabp p1kf158a
23 Oct 20
Draft registration statement (amended)
12:00am
S-1
84cr f7jk
29 Oct 20
IPO registration
5:04pm
10-K
s1i2cjfxb9tekh1w
22 Mar 21
Annual report
4:22pm
8-K
EX-1.1
8kctk5i
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
10-Q
kz7 njipfnrbtap
12 May 21
Quarterly report
4:26pm
424B4
2v0wkvp41bbe e6
9 Apr 21
Prospectus supplement with pricing info
4:02pm
PRE 14A
wa30fk1xb7 z7r4yu
9 Apr 21
Preliminary proxy
4:16pm
DRS
h7u7wjpww6eulo
25 Mar 21
Draft registration statement
12:00am